Search for: "NOVARTIS AG"
Results 181 - 200
of 439
Sorted by Relevance
|
Sort by Date
29 Jul 2016, 12:47 pm
Indianapolis, Indiana - Trademark attorneys for Eli Lilly and Company of Indianapolis, Indiana and Novartis Tiergesundheit AG of Basel, Switzerland filed a lawsuit in the Southern District of Indiana alleging trademark infringement and unfair competition. [read post]
29 Jul 2016, 12:47 pm
Indianapolis, Indiana - Trademark attorneys for Eli Lilly and Company of Indianapolis, Indiana and Novartis Tiergesundheit AG of Basel, Switzerland filed a lawsuit in the Southern District of Indiana alleging trademark infringement and unfair competition. [read post]
11 Apr 2014, 2:20 am
Off-label uses are those uses for which drugs have not been officially approved by drug regulators, eg different therapeutic indications, patient age range or dose instructions [this explanation was vital to this Kat to understand what Silvia was talking about]. [read post]
21 Nov 2017, 2:40 pm
Will Recent ISMP QuarterWatch Report Prompt FDA Regulatory Action, Including Possible Drug Label Change By Novartis? [read post]
21 Mar 2011, 12:44 pm
In July, Novartis AG’s U.S. unit agreed to pay $175 million to settle a long-running discrimination brought by Sanford Wittels. [read post]
26 Aug 2008, 3:28 pm
This one involves Sandoz, the generic drug unit of Novartis AG (NVS), and its metoprolol succinate ER tablets, which is a generic form of AstraZeneca's Toprol XL. [read post]
5 May 2010, 5:14 pm
To add insult to injury, DDMAC determined that the Avantix website, www.bloodleveltesting.com, was registered to Novartis, its content referred to Novartis, and it contained logos for and links to the CML and GIST Alliances. [read post]
25 Sep 2007, 3:00 pm
Marketed in the U.S. by Novartis AG (NVS), Exjade was approved by the FDA for sale in 1995. [read post]
8 Apr 2022, 12:26 am
This week’s newest patent applications from Qualcomm, Novartis, Abbott, Roche, Merck, Medtronic, Boston Scientific, PayPal, Intel, IBM, Microsoft, and Apple. [read post]
5 Jul 2011, 1:44 pm
The patents were owned jointly by MedImmune and MRC, who alleged that they had been infringed by Novartis’ sales of ranibizumab, a pharmaceutical product sold under the trade mark Lucentis and is approved for the treatment of an eye condition known as wet age-related macular degeneration. [read post]
7 Dec 2018, 12:58 am
Only then did the French Patent Office grant the new SPC to Novartis Pharma AG with decision of 4 June 2018. [read post]
6 Jun 2007, 10:30 am
Okay, maybe Novartis needs to fine-tune the formula a bit. [read post]
23 Nov 2023, 1:42 am
Union Of India (Novartis DB), Manu/TN/1263/2007 and Supreme Court decision in Novartis AG[2]Novartis AG v. [read post]
7 Aug 2020, 12:03 pm
Woman Developed Acute And Severe Loss Of Visual Acuity Following Her Second Beovu Injection (Posted by Tom Lamb at DrugInjuryWatch.com) Beovu (brolucizumab) was approved by the FDA in 2019 for the treatment of neovascular (wet) age-related macular degeneration (AMD). [read post]
22 Feb 2019, 3:48 am
Novartis AG v. [read post]
1 Apr 2011, 8:54 pm
For example, the multinational pharmaceutical company Novartis AG entered into an access agreement with the Brazilian Association for the Sustainable Use of the Biodiversity of Amazonia ("BIOAMAZONIA") under whose terms BIOAMAZONIA received an upfront payment of $4,000,000 in return for supplying Novartis with 30,000 promising biological samples over a three-year period; furthermore, should any of these samples lead to a drug that receives… [read post]
17 Oct 2011, 4:53 am
Court of Appeal (Civil Division) Daventry District Council v Daventry & District Housing Ltd [2011] EWCA Civ 1153 (13 October 2011) High Court (Queen’s Bench Division) Woodland v The Swimming Teachers’ Association & Ors [2011] EWHC 2631 (QB) (17 October 2011) High Court (Commercial Court) All Leisure Holidays Ltd v Europaische Reiseversicherung AG & Ors [2011] EWHC 2629 (Comm) (17 October 2011) High Court (Patents Court) Generics (UK) Ltd (t/a Mylan) v… [read post]
28 Jul 2023, 11:46 am
As we mentioned in our earlier article about this developing Syfovre safety signal situation, back in 2020 the ASRS alerted its member doctors about 14 cases of retinal vasculitis in patients after using Beovu, soon after the FDA approved that wet age-related macular degeneration drug from Novartis. [read post]
20 Mar 2012, 7:55 am
On 3 August 2004 Novartis AG lodged a notice of opposition in respect of the goods listed above. [read post]
4 Feb 2008, 5:00 am
.'s Neurontin, Novartis AG's Tegretol and Abbott Laboratories' Depakote â€â [read post]
